Shiying Fu

Title: Shiying Fu: Innovator in Antibody Development

Introduction

Shiying Fu is a prominent inventor based in Beijing, China. He has made significant contributions to the field of biotechnology, particularly in the development of antibodies for therapeutic applications. His work focuses on innovative solutions for treating diseases, including various forms of cancer.

Latest Patents

Shiying Fu holds a patent for "Antibodies or antigen-binding fragments that bind to OX40." This patent provides a detailed disclosure of antibodies that specifically bind to OX40, along with their antigen-binding fragments. The invention outlines the use of these antibodies in treating diseases, particularly cancers. The antibodies or antigen-binding fragments include a heavy chain variable region with one or more CDRs, featuring amino acid sequences as specified in SEQ ID NOs: 1-12. This innovation represents a significant advancement in targeted cancer therapies.

Career Highlights

Shiying Fu is associated with Bioduro (Beijing) Co., Ltd., where he continues to push the boundaries of antibody research. His work at Bioduro has positioned him as a key player in the biotechnology sector, contributing to the development of novel therapeutic agents.

Collaborations

Shiying Fu collaborates with talented professionals in his field, including Jing Li and Guoqian Sun. These collaborations enhance the research and development efforts at Bioduro, fostering an environment of innovation and discovery.

Conclusion

Shiying Fu's contributions to antibody development exemplify the impact of innovative research in biotechnology. His patent on OX40-binding antibodies showcases his commitment to advancing medical treatments for cancer. Through his work, he continues to inspire future innovations in the field.